Reparon-V 1/0.3 Tablet

Repaglinide 1 mg + Voglibose 0.3 mg

Reparon-V 1/0.3 Tablet — Repaglinide 1 mg + Voglibose 0.3 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Repaglinide 1 mg + Voglibose 0.3 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 10 (Alu-Alu)
MRP ₹ 1990
Therapy Cardiac + Diabetic — Meglitinide + biguanide / alpha-glucosidase inhibitor
Storage Store below 25°C.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Reparon-V 1/0.3 Tablet

Reparon-V 1/0.3 Tablet contains Repaglinide 1 mg + Voglibose 0.3 mg. Repaglinide produces a short, rapid insulin spike at mealtimes, providing flexible post-prandial glucose control.

Indicated for type-2 diabetes — particularly in patients with prominent post-prandial hyperglycaemia, irregular meal patterns or older patients prone to hypoglycaemia with long-acting sulphonylureas.

Camrut Healthcare manufactures the Reparon range under WHO-GMP conditions for PCD pharma franchise across India.

Indications

  • Type-2 diabetes with post-prandial hyperglycaemia
  • Patients with irregular meal patterns
  • Elderly type-2 diabetics needing flexible glucose control

Mechanism of Action

Repaglinide is a meglitinide insulin secretagogue. It closes pancreatic beta-cell ATP-sensitive K+ channels (binding a different site than sulphonylureas), depolarising the cell and triggering insulin secretion. Short half-life produces a rapid, post-prandial insulin spike — useful for control of postprandial hyperglycaemia. Voglibose delays intestinal carbohydrate digestion, complementing Repaglinide's post-prandial insulin spike.

Dosage & Administration

['Adults: take 15–30 minutes before each main meal', 'Skip dose if skipping meal', 'Titrate based on glycaemic response', 'Use under physician supervision']

Side Effects

['Hypoglycaemia (less than long-acting sulphonylureas)', 'Weight gain (mild)', 'GI upset']

Contraindications & Precautions

['Type-1 diabetes', 'Diabetic ketoacidosis', 'Severe hepatic impairment', 'Pregnancy and breastfeeding']

Storage

Store below 25°C.

PCD Pharma Franchise & Third-Party Manufacturing
Reparon-V 1/0.3 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.